TMEM5-associated dystroglycanopathy presenting with CMD and mild limb-girdle muscle involvement

Guja Astrea1, Ilaria Pezzini1, Ester Picillo2

  • 1IRCCS Stella Maris, Pisa, Italy.

Insights

Mutations in TMEM5 gene are linked to dystroglycanopathies. This study details a case with milder muscular and distinct brain abnormalities, expanding the known spectrum of TMEM5-associated disorders.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Dystroglycanopathies are neurodegenerative disorders resulting from impaired alpha-dystroglycan glycosylation.
  • Mutations in the TMEM5 gene have recently been associated with severe forms of these conditions.

Observation:

  • A case study of an Italian boy with delayed development, mild muscle weakness, and specific brain malformations (polymicrogyria) was analyzed.
  • The patient presented with moderate intellectual disability, cochlear dysplasia, and a known TMEM5 mutation (p.A47Rfs*42).

Findings:

  • Targeted next-generation sequencing confirmed the TMEM5 mutation.
  • The patient exhibited a milder muscular phenotype and unique structural brain abnormalities compared to previously reported severe cases.

Implications:

  • This case expands the clinical and genetic spectrum of TMEM5-associated disorders.
  • Understanding these variations is crucial for accurate diagnosis and potential therapeutic strategies in dystroglycanopathies.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
728
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K